The surgical robotics firm said that an unauthorized third party accessed customer business and contact information, as well as employee and corporate data.

The medtech company, which identified the attack on Wednesday, revealed in an update that its order processing, manufacturing and shipping have been disrupted.

Along with the significant growth of genetic testing over the past two decades has come a rise in test fraud schemes targeting Medicare beneficiaries. Now, the Trump administration is requesting ...

Combining the disparate databases used to detect potential issues with drugs, vaccines and other products into a single dashboard will enhance their utility and cut costs, the agency said.

The full scope of the impact, including operational and financial effects, is not yet known. Stryker does not have a timeline for full restoration of its systems.

The company is scaling up manufacturing and commercial activities as it prepares to enter the U.S. market via the Food and Drug Administration’s de novo pathway.

The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.

The FDA sent the warning letter after an inspection of Exactech’s Sarasota, Florida, facility in July. At the time of the inspection, Exactech had not yet received court approval to sell its assets ...

MiniMed, Medtronic’s diabetes tech spinoff, made its debut on the public markets Friday. The company started trading on the ...

Expecting pivotal data this year, the company has raised a Series C round to support the launch of a noninvasive device ...

The robotics company, which has taken steps to preserve cash amid the latest change of course in the development of its ...

Biocare’s strong growth in immunohistochemistry is expected to strengthen Agilent’s ability to develop new in vitro diagnostic antibodies.